27.10.2022 - Regulatory News: Genomic Vision (FR0011799907 – GV, – the “Company”) (Paris:GV), a biotechnology company that develops tools and services dedicated to the analysis and control of changes in the genome, today announced its revenue and cash position . Seite 1
Genomic Vision: Financial Information for the Third Quarter of 2022 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.